Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: A dominant or recessive disease?

Pediatric Research

Volumn 47, Issue 3, 2000, Pages 336-343

  Van Der Burg, Mirjam ^b   De Groot, Ronald ^a   Comans Bitter, W Marieke ^b   Den Hollander, Jan C ^b   Hooijkaas, Herbert ^b   Neijens, Herman J ^b   Berger, Rolf M F ^b   Oranje, Arnold P ^b   Langerak, Anton W ^b   Van Dongen, Jacques J M ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHILD; CONSANGUINEOUS MARRIAGE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

EID: 17744410357     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200003000-00009     Document Type: Article

References (34)

1. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM 1995 Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
2. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler-Stevenson M, Strober W 1992 A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334-341
3. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S 1992 Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317
4. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S 1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976
5. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S 1995 Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 11:294-300
6. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N, Nagata S 1996 Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 93:2131-2136
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S 1991 The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
8. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S 1994 Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6:1567-1574
9. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D 1995 FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341-351
10. King LB, Ashwell JD 1994 Thymocyte and T cell apoptosis: is all death created equal? Thymus 23:209-230
11. Osborne BA 1996 Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol 8:245-254
12. Singer GG, Abbas AK 1994 The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365-371
13. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC 1995 CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181-184
14. Lynch DH, Ramsdell F, Alderson MR 1995 Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569-574
15. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD 1994 Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759-1762
16. Behrmann I, Walczak H, Krammer PH 1994 Structure of the human APO-1 gene. Eur J Immunol 24:3057-3062
17. Cheng J, Liu C, Koopman WJ, Mountz JD 1995 Characterization of human Fas gene: exon/intron organization and promoter region. J Immunol 154:1239-1245
18. Inazawa J, Itoh N, Abe T, Nagata S 1992 Assignment of the human Fas antigen (FAS) to 10q 24:1 Genomics 14:821-822
19. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP 1995 Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349
20. Le Deist F, Emile JF, Rieux-Laucat F, Benkerrou M, Roberts I, Brousse N, Fischer A 1996 Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 348:719-723
21. Bettinardi A, Brugnoni D, Quiros-Roldan E, Malagoli A, La Grutta S, Correra A, Notarangelo LD 1997 Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 89:902-909
22. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Lenardo MJ, Straus SE 1997 Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341-1348
23. Infante AJ, Britton HA, DeNapoli T, Middelton LA, Lenardo MJ, Jackson CE, Wang J, Fleisher T, Straus SE, Puck JM 1998 The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 133:629-633
24. Lim MS, Straus SE, Dale JK, Fleisher TA, Stetler-Stevenson M, Strober W, Sneller MC, Puck JM, Lenardo MJ, Elenitoba-Johnson KS, Lin AY, Raffeld M, Jaffe ES 1998 Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol 153:1541-1550
25. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
26. Holland PM, Abramson RD, Watson R, Gelfand DH 1991 Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88:7276-7280
27. Langerak AW, Szczepanski T, van der Burg M, Wolvers-Tettero ILM, van Dongen JJM 1997 Heteroduplex PCR analysis of rearranged T cell receptor genes for the diagnosis of suspected T cell proliferations. Leukemia 11:2192-2199
28. van Dongen JJM, Wolvers-Tettero ILM 1991 Analysis of immunoglobulin and T cell receptor genes: I. Basic and technical aspects. Clin Chim Acta 198:1-91
29. Nagata S, Suda T 1995 Fas and Fas ligand: lpr and gld mutations. Immunol Today 16:39-43
30. Stanger BZ, Leder P, Lee TH, Kim E, Seed B 1995 RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523
31. Grimm S, Stanger BZ, Leder P 1996 RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc Natl Acad Sci USA 93:10923-10927
32. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bertz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM 1996 FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell 85:817-827
33. Muzio M, Salvesen GS, Dixit VM 1997 FLICE induced apoptosis in a cell-free system: cleavage of caspase zymogens. J Biol Chem 272:2952-2956
34. Dianzani U, Bragardo M, DiFranco D, Alliaudi C, Scagni P, Buonfiglio D, Redoglia V, Bonissoni S, Correra A, Dianzani I, Ramenghi U 1997 Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood 89:2871-2879